aluates Reports

$ 0.0

Automative

Global Microarray-based Non-Invasive Prenatal Testing Market Research Report 2026

Published Date: 2026-03-14

Report Code: QYRE-Auto-19O18052

Global Microarray based Non Invasive Prenatal Testing Market Research Report 2024

BUY CHAPTERS

Global Microarray-based Non-Invasive Prenatal Testing Market Research Report 2026

Code: QYRE-Auto-19O18052

Report

2026-03-14

Pages:119

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Agilent Technologies

Ariosa Diagnostics (Roche)

BGI Group

Eurofins LifeCodexx GmbH

Illumina Inc

Laboratory Corporation of America

Myriad Genetics

Natera

PerkinElmer Inc

Quest Diagnostics

Sequenom

Microarray-based Non-Invasive Prenatal Testing Market

The global Microarray-based Non-Invasive Prenatal Testing market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.

For expectant mothers, microarray-based non-invasive prenatal testing (NIPT) provides a secure and educational screening choice. To determine the likelihood of chromosomal abnormalities in the foetus, it examines cell-free foetal DNA that is circulating in the mother's blood. In contrast to conventional techniques that may result in miscarriage, NIPT is a blood test. With a detection rate for Down syndrome that is above 99%, this extremely reliable test yields findings in less than a week. In comparison to earlier techniques, it can even test for a wider spectrum of disorders. However, NIPT is only a screening tool and not a conclusive diagnosis. It could require more testing to be confirmed. It might not be appropriate for all pregnancies, and the cost and insurance coverage can differ.

The North American market for Microarray-based Non-Invasive Prenatal Testing is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Microarray-based Non-Invasive Prenatal Testing is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The global market for Microarray-based Non-Invasive Prenatal Testing in Hospitals & Clinics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.

Major global companies of Microarray-based Non-Invasive Prenatal Testing include Agilent Technologies, Ariosa Diagnostics (Roche), BGI Group, Eurofins LifeCodexx GmbH, Illumina, Laboratory Corporation of America, Myriad Genetics, Natera, PerkinElmer Inc, Quest Diagnostics, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Microarray-based Non-Invasive Prenatal Testing market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Microarray-based Non-Invasive Prenatal Testing. The Microarray-based Non-Invasive Prenatal Testing market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Microarray-based Non-Invasive Prenatal Testing market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Microarray-based Non-Invasive Prenatal Testing manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Microarray-based Non-Invasive Prenatal Testing Market Report

Report Metric	Details
Report Name	Microarray-based Non-Invasive Prenatal Testing Market
Segment by Type	Trisomy Detection Microdeletion Syndromes Other
Segment by Application	Hospitals & Clinics Independent Laboratories
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Agilent Technologies, Ariosa Diagnostics (Roche), BGI Group, Eurofins LifeCodexx GmbH, Illumina, Laboratory Corporation of America, Myriad Genetics, Natera, PerkinElmer Inc, Quest Diagnostics, Sequenom
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Microarray-based Non-Invasive Prenatal Testing companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Microarray-based Non-Invasive Prenatal Testing Market report?

Ans: The main players in the Microarray-based Non-Invasive Prenatal Testing Market are Agilent Technologies, Ariosa Diagnostics (Roche), BGI Group, Eurofins LifeCodexx GmbH, Illumina, Laboratory Corporation of America, Myriad Genetics, Natera, PerkinElmer Inc, Quest Diagnostics, Sequenom

What are the Application segmentation covered in the Microarray-based Non-Invasive Prenatal Testing Market report?

Ans: The Applications covered in the Microarray-based Non-Invasive Prenatal Testing Market report are Hospitals & Clinics, Independent Laboratories

What are the Type segmentation covered in the Microarray-based Non-Invasive Prenatal Testing Market report?

Ans: The Types covered in the Microarray-based Non-Invasive Prenatal Testing Market report are Trisomy Detection, Microdeletion Syndromes, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Microarray-based Non-Invasive Prenatal Testing Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Trisomy Detection

1.2.3 Microdeletion Syndromes

1.2.4 Other

1.3 Market by Application

1.3.1 Global Microarray-based Non-Invasive Prenatal Testing Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Hospitals & Clinics

1.3.3 Independent Laboratories

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Microarray-based Non-Invasive Prenatal Testing Market Perspective (2021–2032)

2.2 Global Microarray-based Non-Invasive Prenatal Testing Growth Trends by Region

2.2.1 Global Microarray-based Non-Invasive Prenatal Testing Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Microarray-based Non-Invasive Prenatal Testing Historic Market Size by Region (2021–2026)

2.2.3 Microarray-based Non-Invasive Prenatal Testing Forecasted Market Size by Region (2027–2032)

2.3 Microarray-based Non-Invasive Prenatal Testing Market Dynamics

2.3.1 Microarray-based Non-Invasive Prenatal Testing Industry Trends

2.3.2 Microarray-based Non-Invasive Prenatal Testing Market Drivers

2.3.3 Microarray-based Non-Invasive Prenatal Testing Market Challenges

2.3.4 Microarray-based Non-Invasive Prenatal Testing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Microarray-based Non-Invasive Prenatal Testing Players by Revenue

3.1.1 Global Top Microarray-based Non-Invasive Prenatal Testing Players by Revenue (2021–2026)

3.1.2 Global Microarray-based Non-Invasive Prenatal Testing Revenue Market Share by Players (2021–2026)

3.2 Global Top Microarray-based Non-Invasive Prenatal Testing Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Microarray-based Non-Invasive Prenatal Testing Revenue

3.4 Global Microarray-based Non-Invasive Prenatal Testing Market Concentration Ratio

3.4.1 Global Microarray-based Non-Invasive Prenatal Testing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Microarray-based Non-Invasive Prenatal Testing Revenue in 2025

3.5 Global Key Players of Microarray-based Non-Invasive Prenatal Testing Head Offices and Areas Served

3.6 Global Key Players of Microarray-based Non-Invasive Prenatal Testing, Products and Applications

3.7 Global Key Players of Microarray-based Non-Invasive Prenatal Testing, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Microarray-based Non-Invasive Prenatal Testing Breakdown Data by Type

4.1 Global Microarray-based Non-Invasive Prenatal Testing Historic Market Size by Type (2021–2026)

4.2 Global Microarray-based Non-Invasive Prenatal Testing Forecasted Market Size by Type (2027–2032)

5 Microarray-based Non-Invasive Prenatal Testing Breakdown Data by Application

5.1 Global Microarray-based Non-Invasive Prenatal Testing Historic Market Size by Application (2021–2026)

5.2 Global Microarray-based Non-Invasive Prenatal Testing Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Microarray-based Non-Invasive Prenatal Testing Market Size (2021–2032)

6.2 North America Microarray-based Non-Invasive Prenatal Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2021–2026)

6.4 North America Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Microarray-based Non-Invasive Prenatal Testing Market Size (2021–2032)

7.2 Europe Microarray-based Non-Invasive Prenatal Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2021–2026)

7.4 Europe Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Size (2021–2032)

8.2 Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Size by Region (2021–2026)

8.4 Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Microarray-based Non-Invasive Prenatal Testing Market Size (2021–2032)

9.2 Latin America Microarray-based Non-Invasive Prenatal Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2021–2026)

9.4 Latin America Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size (2021–2032)

10.2 Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2021–2026)

10.4 Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Agilent Technologies

11.1.1 Agilent Technologies Company Details

11.1.2 Agilent Technologies Business Overview

11.1.3 Agilent Technologies Microarray-based Non-Invasive Prenatal Testing Introduction

11.1.4 Agilent Technologies Revenue in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)

11.1.5 Agilent Technologies Recent Development

11.2 Ariosa Diagnostics (Roche)

11.2.1 Ariosa Diagnostics (Roche) Company Details

11.2.2 Ariosa Diagnostics (Roche) Business Overview

11.2.3 Ariosa Diagnostics (Roche) Microarray-based Non-Invasive Prenatal Testing Introduction

11.2.4 Ariosa Diagnostics (Roche) Revenue in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)

11.2.5 Ariosa Diagnostics (Roche) Recent Development

11.3 BGI Group

11.3.1 BGI Group Company Details

11.3.2 BGI Group Business Overview

11.3.3 BGI Group Microarray-based Non-Invasive Prenatal Testing Introduction

11.3.4 BGI Group Revenue in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)

11.3.5 BGI Group Recent Development

11.4 Eurofins LifeCodexx GmbH

11.4.1 Eurofins LifeCodexx GmbH Company Details

11.4.2 Eurofins LifeCodexx GmbH Business Overview

11.4.3 Eurofins LifeCodexx GmbH Microarray-based Non-Invasive Prenatal Testing Introduction

11.4.4 Eurofins LifeCodexx GmbH Revenue in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)

11.4.5 Eurofins LifeCodexx GmbH Recent Development

11.5 Illumina

11.5.1 Illumina Company Details

11.5.2 Illumina Business Overview

11.5.3 Illumina Microarray-based Non-Invasive Prenatal Testing Introduction

11.5.4 Illumina Revenue in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)

11.5.5 Illumina Recent Development

11.6 Laboratory Corporation of America

11.6.1 Laboratory Corporation of America Company Details

11.6.2 Laboratory Corporation of America Business Overview

11.6.3 Laboratory Corporation of America Microarray-based Non-Invasive Prenatal Testing Introduction

11.6.4 Laboratory Corporation of America Revenue in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)

11.6.5 Laboratory Corporation of America Recent Development

11.7 Myriad Genetics

11.7.1 Myriad Genetics Company Details

11.7.2 Myriad Genetics Business Overview

11.7.3 Myriad Genetics Microarray-based Non-Invasive Prenatal Testing Introduction

11.7.4 Myriad Genetics Revenue in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)

11.7.5 Myriad Genetics Recent Development

11.8 Natera

11.8.1 Natera Company Details

11.8.2 Natera Business Overview

11.8.3 Natera Microarray-based Non-Invasive Prenatal Testing Introduction

11.8.4 Natera Revenue in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)

11.8.5 Natera Recent Development

11.9 PerkinElmer Inc

11.9.1 PerkinElmer Inc Company Details

11.9.2 PerkinElmer Inc Business Overview

11.9.3 PerkinElmer Inc Microarray-based Non-Invasive Prenatal Testing Introduction

11.9.4 PerkinElmer Inc Revenue in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)

11.9.5 PerkinElmer Inc Recent Development

11.10 Quest Diagnostics

11.10.1 Quest Diagnostics Company Details

11.10.2 Quest Diagnostics Business Overview

11.10.3 Quest Diagnostics Microarray-based Non-Invasive Prenatal Testing Introduction

11.10.4 Quest Diagnostics Revenue in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)

11.10.5 Quest Diagnostics Recent Development

11.11 Sequenom

11.11.1 Sequenom Company Details

11.11.2 Sequenom Business Overview

11.11.3 Sequenom Microarray-based Non-Invasive Prenatal Testing Introduction

11.11.4 Sequenom Revenue in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)

11.11.5 Sequenom Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Agilent Technologies

Ariosa Diagnostics (Roche)

BGI Group

Eurofins LifeCodexx GmbH

Illumina Inc

Laboratory Corporation of America

Myriad Genetics

Natera

PerkinElmer Inc

Quest Diagnostics

Sequenom

List of Tables

Table 1. Global Microarray-based Non-Invasive Prenatal Testing Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Trisomy Detection

Table 3. Key Players of Microdeletion Syndromes

Table 4. Key Players of Other

Table 5. Global Microarray-based Non-Invasive Prenatal Testing Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global Microarray-based Non-Invasive Prenatal Testing Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 7. Global Microarray-based Non-Invasive Prenatal Testing Market Size by Region (US$ Million), 2021–2026

Table 8. Global Microarray-based Non-Invasive Prenatal Testing Market Share by Region (2021–2026)

Table 9. Global Microarray-based Non-Invasive Prenatal Testing Forecasted Market Size by Region (US$ Million), 2027–2032

Table 10. Global Microarray-based Non-Invasive Prenatal Testing Market Share by Region (2027–2032)

Table 11. Microarray-based Non-Invasive Prenatal Testing Market Trends

Table 12. Microarray-based Non-Invasive Prenatal Testing Market Drivers

Table 13. Microarray-based Non-Invasive Prenatal Testing Market Challenges

Table 14. Microarray-based Non-Invasive Prenatal Testing Market Restraints

Table 15. Global Microarray-based Non-Invasive Prenatal Testing Revenue by Players (US$ Million), 2021–2026

Table 16. Global Microarray-based Non-Invasive Prenatal Testing Market Share by Players (2021–2026)

Table 17. Global Top Microarray-based Non-Invasive Prenatal Testing Players by Tier (Tier 1, Tier 2, and Tier 3), based on Microarray-based Non-Invasive Prenatal Testing Revenue, 2025

Table 18. Ranking of Global Top Microarray-based Non-Invasive Prenatal Testing Companies by Revenue (US$ Million) in 2025

Table 19. Global 5 Largest Players Market Share by Microarray-based Non-Invasive Prenatal Testing Revenue (CR5 and HHI), 2021–2026

Table 20. Global Key Players of Microarray-based Non-Invasive Prenatal Testing, Headquarters and Area Served

Table 21. Global Key Players of Microarray-based Non-Invasive Prenatal Testing, Products and Applications

Table 22. Global Key Players of Microarray-based Non-Invasive Prenatal Testing, Date of General Availability (GA)

Table 23. Mergers and Acquisitions, Expansion Plans

Table 24. Global Microarray-based Non-Invasive Prenatal Testing Market Size by Type (US$ Million), 2021–2026

Table 25. Global Microarray-based Non-Invasive Prenatal Testing Revenue Market Share by Type (2021–2026)

Table 26. Global Microarray-based Non-Invasive Prenatal Testing Forecasted Market Size by Type (US$ Million), 2027–2032

Table 27. Global Microarray-based Non-Invasive Prenatal Testing Revenue Market Share by Type (2027–2032)

Table 28. Global Microarray-based Non-Invasive Prenatal Testing Market Size by Application (US$ Million), 2021–2026

Table 29. Global Microarray-based Non-Invasive Prenatal Testing Revenue Market Share by Application (2021–2026)

Table 30. Global Microarray-based Non-Invasive Prenatal Testing Forecasted Market Size by Application (US$ Million), 2027–2032

Table 31. Global Microarray-based Non-Invasive Prenatal Testing Revenue Market Share by Application (2027–2032)

Table 32. North America Microarray-based Non-Invasive Prenatal Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 33. North America Microarray-based Non-Invasive Prenatal Testing Market Size by Country (US$ Million), 2021–2026

Table 34. North America Microarray-based Non-Invasive Prenatal Testing Market Size by Country (US$ Million), 2027–2032

Table 35. Europe Microarray-based Non-Invasive Prenatal Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 36. Europe Microarray-based Non-Invasive Prenatal Testing Market Size by Country (US$ Million), 2021–2026

Table 37. Europe Microarray-based Non-Invasive Prenatal Testing Market Size by Country (US$ Million), 2027–2032

Table 38. Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 39. Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Size by Region (US$ Million), 2021–2026

Table 40. Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Size by Region (US$ Million), 2027–2032

Table 41. Latin America Microarray-based Non-Invasive Prenatal Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 42. Latin America Microarray-based Non-Invasive Prenatal Testing Market Size by Country (US$ Million), 2021–2026

Table 43. Latin America Microarray-based Non-Invasive Prenatal Testing Market Size by Country (US$ Million), 2027–2032

Table 44. Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 45. Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size by Country (US$ Million), 2021–2026

Table 46. Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size by Country (US$ Million), 2027–2032

Table 47. Agilent Technologies Company Details

Table 48. Agilent Technologies Business Overview

Table 49. Agilent Technologies Microarray-based Non-Invasive Prenatal Testing Product

Table 50. Agilent Technologies Revenue in Microarray-based Non-Invasive Prenatal Testing Business (US$ Million), 2021–2026

Table 51. Agilent Technologies Recent Development

Table 52. Ariosa Diagnostics (Roche) Company Details

Table 53. Ariosa Diagnostics (Roche) Business Overview

Table 54. Ariosa Diagnostics (Roche) Microarray-based Non-Invasive Prenatal Testing Product

Table 55. Ariosa Diagnostics (Roche) Revenue in Microarray-based Non-Invasive Prenatal Testing Business (US$ Million), 2021–2026

Table 56. Ariosa Diagnostics (Roche) Recent Development

Table 57. BGI Group Company Details

Table 58. BGI Group Business Overview

Table 59. BGI Group Microarray-based Non-Invasive Prenatal Testing Product

Table 60. BGI Group Revenue in Microarray-based Non-Invasive Prenatal Testing Business (US$ Million), 2021–2026

Table 61. BGI Group Recent Development

Table 62. Eurofins LifeCodexx GmbH Company Details

Table 63. Eurofins LifeCodexx GmbH Business Overview

Table 64. Eurofins LifeCodexx GmbH Microarray-based Non-Invasive Prenatal Testing Product

Table 65. Eurofins LifeCodexx GmbH Revenue in Microarray-based Non-Invasive Prenatal Testing Business (US$ Million), 2021–2026

Table 66. Eurofins LifeCodexx GmbH Recent Development

Table 67. Illumina Company Details

Table 68. Illumina Business Overview

Table 69. Illumina Microarray-based Non-Invasive Prenatal Testing Product

Table 70. Illumina Revenue in Microarray-based Non-Invasive Prenatal Testing Business (US$ Million), 2021–2026

Table 71. Illumina Recent Development

Table 72. Laboratory Corporation of America Company Details

Table 73. Laboratory Corporation of America Business Overview

Table 74. Laboratory Corporation of America Microarray-based Non-Invasive Prenatal Testing Product

Table 75. Laboratory Corporation of America Revenue in Microarray-based Non-Invasive Prenatal Testing Business (US$ Million), 2021–2026

Table 76. Laboratory Corporation of America Recent Development

Table 77. Myriad Genetics Company Details

Table 78. Myriad Genetics Business Overview

Table 79. Myriad Genetics Microarray-based Non-Invasive Prenatal Testing Product

Table 80. Myriad Genetics Revenue in Microarray-based Non-Invasive Prenatal Testing Business (US$ Million), 2021–2026

Table 81. Myriad Genetics Recent Development

Table 82. Natera Company Details

Table 83. Natera Business Overview

Table 84. Natera Microarray-based Non-Invasive Prenatal Testing Product

Table 85. Natera Revenue in Microarray-based Non-Invasive Prenatal Testing Business (US$ Million), 2021–2026

Table 86. Natera Recent Development

Table 87. PerkinElmer Inc Company Details

Table 88. PerkinElmer Inc Business Overview

Table 89. PerkinElmer Inc Microarray-based Non-Invasive Prenatal Testing Product

Table 90. PerkinElmer Inc Revenue in Microarray-based Non-Invasive Prenatal Testing Business (US$ Million), 2021–2026

Table 91. PerkinElmer Inc Recent Development

Table 92. Quest Diagnostics Company Details

Table 93. Quest Diagnostics Business Overview

Table 94. Quest Diagnostics Microarray-based Non-Invasive Prenatal Testing Product

Table 95. Quest Diagnostics Revenue in Microarray-based Non-Invasive Prenatal Testing Business (US$ Million), 2021–2026

Table 96. Quest Diagnostics Recent Development

Table 97. Sequenom Company Details

Table 98. Sequenom Business Overview

Table 99. Sequenom Microarray-based Non-Invasive Prenatal Testing Product

Table 100. Sequenom Revenue in Microarray-based Non-Invasive Prenatal Testing Business (US$ Million), 2021–2026

Table 101. Sequenom Recent Development

Table 102. Research Programs/Design for This Report

Table 103. Key Data Information from Secondary Sources

Table 104. Key Data Information from Primary Sources

Table 105. Authors List of This Report

List of Figures

Figure 1. Microarray-based Non-Invasive Prenatal Testing Picture

Figure 2. Global Microarray-based Non-Invasive Prenatal Testing Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Microarray-based Non-Invasive Prenatal Testing Market Share by Type: 2025 vs 2032

Figure 4. Trisomy Detection Features

Figure 5. Microdeletion Syndromes Features

Figure 6. Other Features

Figure 7. Global Microarray-based Non-Invasive Prenatal Testing Market Size by Application (US$ Million), 2021–2032

Figure 8. Global Microarray-based Non-Invasive Prenatal Testing Market Share by Application: 2025 vs 2032

Figure 9. Hospitals & Clinics Case Studies

Figure 10. Independent Laboratories Case Studies

Figure 11. Microarray-based Non-Invasive Prenatal Testing Report Years Considered

Figure 12. Global Microarray-based Non-Invasive Prenatal Testing Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 13. Global Microarray-based Non-Invasive Prenatal Testing Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 14. Global Microarray-based Non-Invasive Prenatal Testing Market Share by Region: 2025 vs 2032

Figure 15. Global Microarray-based Non-Invasive Prenatal Testing Market Share by Players in 2025

Figure 16. Global Microarray-based Non-Invasive Prenatal Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 17. The Top 10 and 5 Players Market Share by Microarray-based Non-Invasive Prenatal Testing Revenue in 2025

Figure 18. North America Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 19. North America Microarray-based Non-Invasive Prenatal Testing Market Share by Country (2021–2032)

Figure 20. United States Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 21. Canada Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. Europe Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Europe Microarray-based Non-Invasive Prenatal Testing Market Share by Country (2021–2032)

Figure 24. Germany Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. France Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. U.K. Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. Italy Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Russia Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Ireland Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Share by Region (2021–2032)

Figure 32. China Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Japan Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. South Korea Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Southeast Asia Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. India Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Australia & New Zealand Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Latin America Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Latin America Microarray-based Non-Invasive Prenatal Testing Market Share by Country (2021–2032)

Figure 40. Mexico Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Brazil Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Share by Country (2021–2032)

Figure 44. Israel Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Saudi Arabia Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. UAE Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Agilent Technologies Revenue Growth Rate in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)

Figure 48. Ariosa Diagnostics (Roche) Revenue Growth Rate in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)

Figure 49. BGI Group Revenue Growth Rate in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)

Figure 50. Eurofins LifeCodexx GmbH Revenue Growth Rate in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)

Figure 51. Illumina Revenue Growth Rate in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)

Figure 52. Laboratory Corporation of America Revenue Growth Rate in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)

Figure 53. Myriad Genetics Revenue Growth Rate in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)

Figure 54. Natera Revenue Growth Rate in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)

Figure 55. PerkinElmer Inc Revenue Growth Rate in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)

Figure 56. Quest Diagnostics Revenue Growth Rate in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)

Figure 57. Sequenom Revenue Growth Rate in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Non Invasive Prenatal Testing Kit Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Noninvasive Prenatal Testing Service Market Research Report 2025

Non invasive Prenatal Testing Equipment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Non Invasive Prenatal Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Non Invasive Prenatal Testing NIPT Market Research Report 2024

Global Non Invasive Prenatal Testing Devices Market Insights Forecast to 2030

Global Non invasive Parenteral Screening Market Insights Forecast to 2030

Global Non Invasive Prenatal DNA Testing Service Market Research Report 2024

Global Non invasive Preimplantation Genetic Testing Market Research Report 2024

Global Non invasive Parenteral Screening Instruments Market Insights Forecast to 2030

Global Non invasive Prenatal Paternity Testing NIPPT Market Research Report 2024

Global Non Invasive Prenatal Screening NIPS Market Research Report 2024

Global Prenatal Genetic Screening Test Market Research Report 2024

Global Non Invasive Cancer Detection Market Research Report 2024

Global Noninvasive Prenatal Gene Testing Technology Market Research Report 2024

Global SNP Microarray Testing and Analysis Market Research Report 2025

Global Prenatal DNA Sequencing Market Size Status and Forecast 2021 2027

Global Down Syndrome Genetic Testing Market Research Report 2024

Global High throughput Sequencing System Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions